Fumagillin and fumarranol interact with P. falciparum methionine aminopeptidase 2 and inhibit malaria parasite growth in vitro and in vivo.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Chemistry and Biology

• Publication date

  2009-02-27

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.chembiol.2009.01.006PMID 19246010
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Regulation of c-Src nonreceptor tyrosine kinase activity by bengamide A through inhibition of methionine aminopeptidases.

  2007cited by this paper
• Inhibition of monometalated methionine aminopeptidase: inhibitor discovery and crystallographic analysis.

  2007cited by this paper
• Autoproteolysis of rat p67 generates several peptide fragments: the N-terminal fragment, p26, is required for the protection of eIF2alpha from phosphorylation.

  2007cited by this paper
• Inhibitors of Plasmodium falciparum methionine aminopeptidase 1b possess antimalarial activity

  2006cited by this paper
• The binding between p67 and eukaryotic initiation factor 2 plays important roles in the protection of eIF2alpha from phosphorylation by kinases.

  2006cited by this paper
• The N-terminal lysine residue-rich domain II and the 340-430 amino acid segment of eukaryotic initiation factor 2-associated glycoprotein p67 are the binding sites for the gamma-subunit of eIF2.

  2006cited by this paper
• Fumarranol, a rearranged fumagillin analogue that inhibits angiogenesis in vivo.

  2006cited by this paper
• Elucidation of the function of type 1 human methionine aminopeptidase during cell cycle progression

  2006cited by this paper
• Catabolism of intracellular N-terminal acetylated proteins: involvement of acylpeptide hydrolase and acylase.

  2005cited by this paper
• Recombinant protein folding and misfolding in Escherichia coli

  2004cited by this paper
• Analysis of the compositional biases in Plasmodium falciparum genome and proteome using Arabidopsis thaliana as a reference.

  2004cited by this paper
• The 1.15A crystal structure of the Staphylococcus aureus methionyl-aminopeptidase and complexes with triazole based inhibitors.

  2003cited by this paper
• A glycosylation site, 60SGTS63, of p67 is required for its ability to regulate the phosphorylation and activity of eukaryotic initiation factor 2alpha.

  2003cited by this paper
• Negative regulation of the protection of eIF2alpha phosphorylation activity by a unique acidic domain present at the N-terminus of p67.

  2003cited by this paper
• Yeast methionine aminopeptidase type 1 is ribosome‐associated and requires its N‐terminal zinc finger domain for normal function in vivo *

  2002cited by this paper
• Angiogenesis Inhibitors Specific for Methionine Aminopeptidase 2 as Drugs for Malaria and Leishmaniasis

  2002influential reference
• Protection of translation initiation factor eIF2 phosphorylation correlates with eIF2-associated glycoprotein p67 levels and requires the lysine-rich domain I of p67.

  2001cited by this paper
• TNP-470: an angiogenesis inhibitor in clinical development for cancer

  2000cited by this paper
• A Phase I and pharmacokinetic study of TNP-470 administered weekly to patients with advanced cancer.

  1999cited by this paper
• Expression and activity of p67 are induced during heat shock.

  1998cited by this paper
• Structure of human methionine aminopeptidase-2 complexed with fumagillin.

  1998cited by this paper
• Molecular recognition of angiogenesis inhibitors fumagillin and ovalicin by methionine aminopeptidase 2.

  1998influential reference
• Methionine aminopeptidase (type 2) is the common target for angiogenesis inhibitors AGM-1470 and ovalicin.

  1997influential reference
• The anti-angiogenic agent fumagillin covalently binds and inhibits the methionine aminopeptidase, MetAP-2.

  1997cited by this paper
• p67 Transcription Regulates Translation in Serum-starved and Mitogen-activated KRC-7 Cells*

  1997cited by this paper
• Plasmodium falciparum AARP1, a giant protein containing repeated motifs rich in asparagine and aspartate residues, is associated with the infected erythrocyte membrane

  1997cited by this paper
• Effects of albendazole, fumagillin, and TNP-470 on microsporidial replication in vitro

  1997cited by this paper
• A three-hybrid system for detecting small ligand-protein receptor interactions.

  1996cited by this paper
• The N-end rule: functions, mysteries, uses.

  1996cited by this paper
• Evidence that the human homologue of a rat initiation factor-2 associated protein (p67) is a methionine aminopeptidase.

  1996influential reference
• Amino-terminal protein processing in Saccharomyces cerevisiae is an essential function that requires two distinct methionine aminopeptidases.

  1995cited by this paper
• Glycosylation of eukaryotic peptide chain initiation factor 2 (eIF-2)-associated 67-kDa polypeptide (p67) and its possible role in the inhibition of eIF-2 kinase-catalyzed phosphorylation of the eIF-2 alpha-subunit.

  1989cited by this paper
• Methionine aminopeptidase gene of Escherichia coli is essential for cell growth

  1989cited by this paper
• Human malaria parasites in continuous culture.

  1976cited by this paper

• Generation of Noncanonical Fumagillin Derivatives with a Twisted Cyclohexane Conformation through Engineered Biosynthesis.

  2025cites this paper
• Identification of fungal natural products with potent inhibition in Toxoplasma gondii

  2024influential citation
• Plasmodium falciparum Proteases as new drug targets with special focus on Metalloproteases.

  2024cites this paper
• Antimalarial activity of borrelidin and fumagilin in Plasmodium berghei-infected mice

  2024cites this paper
• Fumagillin inhibits growth of the enteric protozoan parasite Entamoeba histolytica by covalently binding to and selectively inhibiting methionine aminopeptidase 2

  2023cites this paper
• Parasite metalo-aminopeptidases as targets in human infectious diseases.

  2023cites this paper
• Molecular characterization of methionine aminopeptidase1 from Eimeria tenella.

  2023cites this paper
• Antimalarial Natural Products.

  2022cites this paper
• Bacterial metalo-aminopeptidases as targets in human infectious diseases.

  2022cites this paper
• TriTOX: A novel Trichomonas vaginalis assay platform for high-throughput screening of compound libraries

  2021cites this paper
• Metalloaminopeptidases of the Protozoan Parasite Plasmodium falciparum as Targets for the Discovery of Novel Antimalarial Drugs.

  2021cites this paper
• TgMAP1c is involved in apicoplast biogenesis in Toxoplasma gondii.

  2020cites this paper
• Antimalarial agents acting on hemoglobin degradation

  2020cites this paper
• Discovery and Preclinical Development of Antigiardiasis Fumagillol Derivatives

  2020cites this paper
• Drug resistance in Giardia: Mechanisms and alternative treatments for Giardiasis.

  2020cites this paper
• Unpacking the Pathogen Box—An Open Source Tool for Fighting Neglected Tropical Disease

  2019cites this paper
• Fumagillin, a Mycotoxin of Aspergillus fumigatus: Biosynthesis, Biological Activities, Detection, and Applications

  2019cites this paper
• Structural and functional highlights of methionine aminopeptidase 2 from Leishmania donovani.

  2018cites this paper
• Metallopeptidases of Toxoplasma gondii: in silico identification and gene expression

  2018cites this paper
• Proteases as antimalarial targets: strategies for genetic, chemical, and therapeutic validation

  2017cites this paper
• Study on synthesis and bioactivity of biotinylated emodin

  2017cites this paper
• Improved computational model of the malaria metabolic network and flux analysis for drug target prediction

  2017cites this paper
• The proteolytic repertoire of malaria parasites

  2016cites this paper
• Defining the targets of antiparasitic compounds.

  2016cites this paper
• Evaluation of Fumagilin-B® and other potential alternative chemotherapies against Nosema ceranae-infected honeybees (Apis mellifera) in cage trial assays

  2016cites this paper
• Molecular and biochemical characterization of methionine aminopeptidase of Babesia bovis as a potent drug target.

  2016influential citation
• Chemical Dimerizers in Three-Hybrid Systems for Small Molecule-Target Protein Profiling.

  2016cites this paper
• Advances in Malaria Research

  2016cites this paper
• Metal promiscuity and metal-dependent substrate preferences of Trypanosoma brucei methionine aminopeptidase 1.

  2015cites this paper
• Cheaper faster drug development validated by the repositioning of drugs against neglected tropical diseases

  2015cites this paper
• Pros and Cons of Protein Manufacturing: Leverage Omics Data in Research, Diagnostics and Drug Discovery

  2015cites this paper
• Fumagillin and Dicyclohexylamine in Apiculture

  2015cites this paper
• Expression and biochemical characterization of a type I methionine aminopeptidase of Plasmodium vivax.

  2015cites this paper
• Fumagillin: an overview of recent scientific advances and their significance for apiculture.

  2014cites this paper
• Discovery of Novel Antigiardiasis Drug Candidates

  2014cites this paper
• From crystal to compound: structure-based antimalarial drug discovery.

  2014cites this paper
• Lipid nanocarriers and molecular targets for malaria chemotherapy.

  2014cites this paper
• Toxoplasma gondii Chemical Biology

  2014cites this paper
• Aminopeptidase N1 (EtAPN1), an M1 Metalloprotease of the Apicomplexan Parasite Eimeria tenella, Participates in Parasite Development

  2014cites this paper
• Working in concert: the metalloaminopeptidases from Plasmodium falciparum.

  2013influential citation
• Green roof technology: investigation of crumb rubber effects on microbial growth

  2013cites this paper
• Proteomic analysis of different period excretory secretory products from Clonorchis sinensis adult worms: molecular characterization, immunolocalization, and serological reactivity of two excretory secretory antigens—methionine aminopeptidase 2 and acid phosphatase

  2013cites this paper
• Cryptostatin, a chagasin-family cysteine protease inhibitor of Cryptosporidium parvum

  2012cites this paper
• Characterization of the biochemical properties of two methionine aminopeptidases of Cryptosporidium parvum.

  2012cites this paper
• Electrophilic natural products and their biological targets.

  2012cites this paper
• Analyse intégrative du rôle de l’excision de la méthionine N-terminale dans le cytoplasme des eucaryotes supérieurs

  2011influential citation
• Two methionine aminopeptidases from Acinetobacter baumannii are functional enzymes.

  2011cites this paper
• A High-Throughput Absorbance-Based Assay for Methionine Produced by Methionine Aminopeptidase Using S-Adenosyl-L-Methionine Synthetase

  2011cites this paper
• DiazoReagentswithSmallStericFootprintsforSimultaneousArming/ SARStudiesofAlcohol-ContainingNaturalProductsviaOHInsertion

  2011cites this paper
• Synthesis of new (-)-bestatin-based inhibitor libraries reveals a novel binding mode in the S1 pocket of the essential malaria M1 metalloaminopeptidase.

  2011cites this paper
• Diazo reagents with small steric footprints for simultaneous arming/SAR studies of alcohol-containing natural products via O-H insertion.

  2011cites this paper
• High-Throughput Giardia lamblia Viability Assay Using Bioluminescent ATP Content Measurements

  2010cites this paper
• Molecular cloning and characterization of a gene encoding methionine aminopeptidase 2 of Schistosoma japonicum

  2010cites this paper
• Proteases of Plasmodium falciparum as potential drug targets and inhibitors thereof.

  2010cites this paper
• Use of thermal melt curves to assess the quality of enzyme preparations.

  2010cites this paper
• Antiparasitic activities of novel, orally available fumagillin analogs.

  2009cites this paper
• Plasmodium falciparum: new molecular targets with potential for antimalarial drug development

  2009cites this paper